DNA Electronics Ltd, a developer of disposable, real-time gene testing at the point-of-care, has been named as the winner of the prestigious R&D prize at the Elektra09 European Electronics Industry Awards.
The Sri Lankan Healthcare and Nutrition Ministry will receive 380,000 Novel Influenza (A) H1N1 vaccines from the World Health Organization (WHO) to cure patients suffering from swine flu in the country.
Wockhardt and Sun Pharmaceutical have received final approval from the United States Food and Drug Administration (USFDA) to market generic versions of Nicardipine, the hypertension drug.
Bharat Biotech International, a leading manufacturer of vaccines and biotherapeutics announced its Anti-Staphylococcal Molecule
Shares of fourteen drug makers rose by 0.99% to 6.16% on reports global pharma firms are scouting for acquiring Indian drug makers, as generic penetration in the developed market is expected to increase in the coming years.
At a time when global multinational drug makers are slashing their workforces to reduce costs, their Indian counterparts are on a hiring spree.
Patent expiry will be a major avenue of growth for the Indian pharmaceutical industry as products worth $235 billion are going off patent within horizon of five years (from 2009 to 2014).
Finally,the government has fulfilled the demand of pharmaceutical industry to meet its long-standing demand of trained manpower by giving in principle approval for setting up of six National Institutes of Pharmaceutical Education and Research (NIPER)
New laws in Kansas and Missouri, prescribe a methamphetamine cook shouldn
Introduction of pentavalent vaccine in the National Immunisation Programme, was kept pending for quite a while, is likely to take off soon.
Retail pharmacy management software business was sold by Arcadia for $2.2 million, cash, to an undisclosed pharmacy benefits management company.
FDBE with The Guild of Healthcare Pharmacists (GHP) and the UK Clinical Pharmacy Association (UKCPA), are pleased to announce the 2010 FDBE/GHP/UKCPA Information Technology Award.
On Tuesday, drug maker GlaxoSmithKline (GSK), established a US $600 million plant in Singapore that is stated to begin producing anti-pneumonia vaccine in 2011.
